FNA (Paragon 28 Inc.) EV/EBITDA Multiple
Paragon 28, Inc. (FNA) generates revenue by supplying advanced implantation systems to orthopedic surgeons and clinics treating lower extremity injuries. High switching costs and FDA patent protection create a robust defensive moat. This price chart, serving as the primary valuation tool with the metric, complements the analysis of the digital planning ecosystem that firmly locks physicians into Paragon 28, Inc. (FNA) solutions.
Summary analytical data breakdowns for paragon28.com (FNA)
- stock price and consensus target price:
- business market valuation indicators:
- issuer book value statistics:
- debt and liquidity data:
- financial results and valuation multiples details:
FNA - Net Income|Projected Future Earnings Paragon 28, Inc.|FNA - P/E Multiple|Future Price to Earnings Paragon 28|FNA - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Paragon 28, Inc.|FNA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Paragon 28|FNA - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months paragon28.com|FNA - Net earnings per share change in current year|Expected earnings per share growth for next year Paragon 28, Inc.
Initial company analysis:Paragon 28 Corp FNA
This indicator determines the business value relative to its operating profit before depreciation, taxes, and interest. Analyzing the EV/EBITDA valuation multiple allows for a comparison of market capitalization and net debt against the actual ability to generate cash flow. For Paragon 28, Inc. (FNA), with its high margins and demand for Apex implants, this metric serves as a critical filter for assessing whether the market is overpaying for rapid revenue growth.
Competitor analysis for Paragon 28, Inc.
Boston Scientific Inc - Enterprise Value to EBITDA Ratio|EW (Edwards Lifesciences Inc.) - Company Value to Operating Income Before Depreciation Ratio|ResMed Inc. - EV/EBITDA Multiple|Company Value to EBITDA insulet.com|ZBH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation COO|Enterprise Value to EBITDA Ratio ALGN|GMED: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TransMedics (TMDX)|Enterprise Value to EBITDA Ratio atecspine.com ATEC|EV/EBITDA Multiple AORT (Artivion)|Enovis Corp (ENOV) - Company Value to EBITDA|Integra - EV/EBITDA Multiple|ESTA (Establishment Labs Inc) - Enterprise Value to Operating Income Before Depreciation|BBNX: EV/EBITDA Multiple|IRMD - Total Company Value to Operating Income Before Depreciation Ratio|EMBC (Embecta) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Tandem Diabetes Care Inc (TNDM)|EV/EBITDA Multiple AXGN|EV/EBITDA Multiple SI-BONE Medical (SIBN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orthofix Medical Inc. OFIX|bioventus.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KIDS: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TMCI (Treace Medical Concepts Inc)|SRTA: EV/EBITDA Multiple|Company Value to EBITDA Carlsmed Medical (CARL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RxSight, Inc.|CLPT - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio STXS (Stereotaxis)|EV/EBITDA Multiple Neuronetics Inc. (STIM)|EV/EBITDA Multiple SGHT (Sight Sciences, Inc)|Total Company Value to Operating Income Before Depreciation Ratio orchestrabiomed.com (OBIO)|ANIK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Vivani Medical|XTNT (Xtant Medical Holdings, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA NeuroOne Medical Technologies Corp. NMTC|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Modular Medical (MODD)|myomo.com - Enterprise Value to Operating Income Before Depreciation|Envoy Medical - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio VVOS (Vivos Therapeutics Inc.)|NVNO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio SINT|TNON: EV/EBITDA Multiple|rewalk.com (LFWD) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Autonomix Medical Inc.|IVF: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BBLG|EV/EBITDA Multiple Axonics, Inc (AXNX)|EV/EBITDA Multiple BIOL (BIOLASE, Inc.)|Enterprise Value to EBITDA Multiple Dynatronics Corp|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
